HUNAN FANGSHENG PHARMACEUTICAL CO., LTD.

News Hunan Fangsheng Pharmaceutical Co., Ltd.

Equities

603998

CNE100001VG6

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
12.03 ^CNY	-0.74%		-3.37%	+9.76%

Apr. 19	Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 10	Fangsheng Pharma's Factories Pass GMP Inspection	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 19	CI
Fangsheng Pharma's Factories Pass GMP Inspection	Apr. 10	MT
Fangsheng Pharma Gets 12.1 Million Yuan in Government Grants in January-March	Apr. 08	MT
Fangsheng Pharma Withdraws Drug Registration Application For Headache Treatment	Dec. 01	MT
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-20	CI
Fangsheng Pharma's Drugs Placed in 2022 Chinese Drug Catalogue	23-01-20	MT
Hunan Fangsheng Pharmaceutical Sees Up to 357% Surge in 2022 Profit; Shares Jump 3%	23-01-19	MT
Hunan Fangsheng Pharma Unit to Resume Work After Leakage Forces Suspension	22-12-15	MT
Hunan Fangsheng Pharmaceutical's Chinese Medicine Extraction Line Passes Regulatory Inspection	22-12-06	MT
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-30	CI
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-30	CI
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-28	CI
Hunan Fangsheng Pharmaceutical Co., Ltd. announced that it expects to receive CNY 269.999999 million in funding	22-03-03	CI
Hunan Fangsheng Pharmaceutical Co., Ltd. announced a financing transaction	22-03-03	CI
Hunan Fangsheng Ruixin Pharmaceutical Co., Ltd. announced that it expects to receive CNY 160 million in funding from Hunan Fangsheng Pharmaceutical Co., Ltd., Changsha Xingchen Kangrui Venture Capital Partnership Enterprise (Limited Partnership), and another investor	21-12-29	CI
China shares end lower as rising local COVID-19 cases drag consumer firms	21-12-27	RE
Guo Jianjun agree to acquire 50% stake in Hunan Hengxing Pharmaceutical Technology Co., Ltd. from Hunan Fangsheng Pharmaceutical Co., Ltd. for CNY 9.4 million.	21-12-17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hunan Fangsheng Pharmaceutical Co., Ltd.

Equities

603998

CNE100001VG6

Summary

Filters